$2.54 -0.09 (%) Celsion Corporation - NASDAQ

Oct. 22, 2014 | 04:00 PM

Partner Headlines

  1. Morning Market Movers

    Benzinga | Jul. 24, 2014 | 09:44AM EST
  2. Benzinga's M&A Chatter for Tuesday June 10, 2014

    Benzinga | Jun. 10, 2014 | 17:57PM EST
  3. Celsion to Present Updated Overall Survival Results from HEAT Study of ThermoDox at ECIO 2014

    Benzinga | Apr. 24, 2014 | 07:14AM EST
  4. Celsion Says Recent Analysis Indicates ThermoDox Could Significantly Improve Overall Survival

    Benzinga | Apr. 10, 2014 | 08:24AM EST
  5. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE Moving Higher, ELGX, DECK, MDVN, CGEN, ARNA Lowr

    Benzinga | Feb. 28, 2014 | 10:40AM EST
  6. Celsion Announces $15M At-The-Market Registered Direct Offering

    Benzinga | Jan. 15, 2014 | 09:09AM EST
  7. Morning Market Movers

    Benzinga | Dec. 13, 2013 | 10:02AM EST
  8. Celsion Presents Combined Clinical Data from Two Phase I Trials

    Benzinga | Dec. 13, 2013 | 08:03AM EST
  9. Celsion Announces Zhejiang HISUN Pharmaceutical does Not Plan to Pursue Exclusive Option to License ThermoDox for China

    Benzinga | Feb. 5, 2013 | 12:38PM EST
  10. Stocks Hitting 52-Week Lows

    Benzinga | Feb. 4, 2013 | 03:19AM EST
  11. Celsion Halted Wednesday, Says Will Host Conference Call Jan 31

    Benzinga | Jan. 30, 2013 | 09:43AM EST
  12. Option Speculators Circle Celsion

    SchaeffersResearch | Jan. 17, 2013 | 12:44PM EST
  13. Stocks Hitting 52-Week Highs

    Benzinga | Dec. 12, 2012 | 03:17AM EST
  14. UPDATE: Dawson James Initiates Celsion at Market Outperform on Phase III Catalyst

    Benzinga | Nov. 27, 2012 | 07:02AM EST
  15. Celsion Corp Says Continuing Phase 2 Study

    Benzinga | Oct. 1, 2012 | 02:19AM EST
  16. Celsion Corporation (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus | Sep. 14, 2012 | 11:10AM EST
  17. Celsion Thermodox Gets Orphan Drug Status in US/Europe

    Benzinga | Sep. 14, 2012 | 02:07AM EST
  18. Health Care Sector Wrap

    FoxBusiness | Aug. 23, 2012 | 10:42AM EST
  19. Gap, General Motors Among Stocks Up on High Volume Friday

    FoxBusiness | Aug. 17, 2012 | 06:33AM EST
  20. Call Volume Surges as Celsion Extends Its Rally

    SchaeffersResearch | Jun. 25, 2012 | 14:56PM EST
  21. Celsion Announces Collaboration With the University of Oxford for First Ever Clinical Trial Using a Targeted Chemotherapeutic Drug Released by Ultrasound to Treat Cancer

    Benzinga | Jun. 7, 2012 | 02:11AM EST
  22. Celsion Announces Resubmission With Philips Healthcare of Combined IND/IDE Application for a Phase 2 Study of ThermoDox(R) and MR-Guided HIFU in Bone Cancer

    Benzinga | May. 14, 2012 | 04:19AM EST
  23. Celsion Announces ThermoDox Commercial Supply Agreement With Hisun

    Benzinga | May. 7, 2012 | 02:42AM EST
  24. Rodman & Renshaw Maintains Outperform on Celsion

    Benzinga | Dec. 20, 2011 | 05:21AM EST
  25. Celsion Completes Consultative Review Process With EMA for Phase III HEAT Study of ThermoDox in Primary Liver Cancer

    Benzinga | Dec. 19, 2011 | 02:52AM EST
  26. Celsion Corp. (CLSN) CEO Michael H Tardugno buys 5,000 Shares

    GuruFocus | Dec. 7, 2011 | 03:57AM EST
  27. Celsion Corp. (CLSN) CFO Gregory L Weaver buys 5,000 Shares

    GuruFocus | Dec. 7, 2011 | 03:57AM EST
Trading Center